Filing Flows › BioScience Health Innovations (BHIC) › Q1 2026
BioScience Health Innovations (BHIC) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 11, 2026
BioScience Health Innovations (BHIC) reported revenue of $751K for the first quarter 2026 (Q1 2026), -39% from a year earlier and -52% from the quarter before. Operating margin was -30.6%, net loss $230K (30.6% of revenue).
BioScience Health Innovations, Q1 2026: revenue $751K (-39% year over year), operating margin -30.6%, net loss $230K, operating cash flow −$552K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $751K | -52% | -39% |
| Operating profit | −$230K | — | -154% |
| Net earnings | −$230K | — | -154% |
| Operating cash flow | −$552K | — | -268% |
What changed
Revenue was $751K in Q1 2026, down 39% year over year and down 52% from the previous quarter.
Gross margin was 64.7%, down 8.4 points from Q1 2025. Operating costs exceeded revenue by $230K, an operating margin of -30.6%. Operating expenses grew 52% against a revenue fall of 39%. The quarter ended with a net loss of $230K, narrower than the previous quarter's $234K loss.
Operating cash flow was −$552K. Working capital and other items used $322K.
Questions
What was BioScience Health Innovations' revenue in the first quarter 2026?
BioScience Health Innovations (BHIC) reported revenue of $751K for the first quarter 2026 (Q1 2026), -39% from a year earlier and -52% from the quarter before.
Was BioScience Health Innovations profitable in the first quarter 2026?
Operating loss was $230K (-30.6% of revenue) and net loss $230K.